Scientific

MK5 Microarray Data


Affected Genes - Ontology Breakdown - Gene Enrichment - Proteome Analysis

These are the micro-array results of a differential gene expression microarray experiments and the subsequent analysis steps performed on them. The up/down- regulation ratio was obtained by measuring WT cells against MK5 activated cells. See material and methods for technical information as well as the data usage policy.

MK5 Proteome Analysis

Table 3: Type II network, divided ranks. This table presents the output of the simulation of a type-II network in which we relied on the high confidence interactions and micro-array results. The output of the micro-array was then ranked and these ranks used as input into the network simulation. After performing two such simulations (one for the MK5 off and one for the MK5 on microarray output), we divided the ranks and sorted the results accordingly. The output of this technique is a collection of proteins that cluster naturally together.


Navigation/Query Panel:
Click on the attribute name to hide/unhide it. The green arrows can be used to shift columns left/right. Exact word match is written as =..., regular expressions can be matched with ~.... To select all values larger or equal than use >.... This would be <... for values smaller or equal than. To select all values within a specific range use [...,...].
Rank Gene description Value Type Network Comparison Type Interaction Map Filtered red green network_comparison
Results: HTML CSV LaTeX Showing element 3958 to 4007 of 6456 in total
Value Type: Measured
Interaction Map: High confidence
Filtered: 1
\def\wcA{0.14285714285714\textwidth} \def\wcB{0.14285714285714\textwidth} \def\wcC{0.14285714285714\textwidth} \def\wcD{0.14285714285714\textwidth} \def\wcE{0.14285714285714\textwidth} \def\wcF{0.14285714285714\textwidth} \begin{longtable}{|c|c|c|c|c|c|} \hline \parbox{\wcA}{\vspace{3pt}\noindent Rank\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent description\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent Network Comparison Type\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent red\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent green\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent network\_comparison\vspace{3pt}}\\ \hline \hline \parbox{\wcA}{\vspace{3pt}\noindent 1979\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent kinesin heavy chain (ubiquitous kinesin heavy chain) (ukhc). [source:swissprot;acc:p33176]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 6036.68\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 6379.44\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 342.76\vspace{3pt}}\\\hline \multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent 1980\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent bile acid coenzyme a: amino acid n-acyltransferase; glycine n-choloyltransferase. [source:refseq;acc:nm\_001701]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 5830.46\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 6176.71\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 1.05939\vspace{3pt}}\\\cline{2-6} &\parbox{\wcB}{\vspace{3pt}\noindent kinesin heavy chain isoform 5c (kinesin heavy chain neuron-specific 2). [source:swissprot;acc:o60282]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 6036.68\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 6379.44\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 342.76\vspace{3pt}}\\\hline \multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent 1981\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent inositol polyphosphate 5-phosphatase ocrl-1 (ec 3.1.3.36) (lowe's oculocerebrorenal syndrome protein). [source:swissprot;acc:q01968]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 5475.74\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 5800.97\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 1.05939\vspace{3pt}}\\\cline{2-6} &\parbox{\wcB}{\vspace{3pt}\noindent neuronal kinesin heavy chain (nkhc) (kinesin heavy chain isoform 5a) (kinesin heavy chain neuron-specific 1). [source:swissprot;acc:q12840]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent Subtracted\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent 6036.68\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent 6379.44\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent 342.76\vspace{3pt}}}\\\cline{1-2} \multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent 1982\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent transcription factor iiia (factor a) (tfiiia). [source:swissprot;acc:q92664]\vspace{3pt}}&&&&\\\cline{2-6} &\parbox{\wcB}{\vspace{3pt}\noindent uv excision repair protein rad23 homolog b (hhr23b) (xp-c repair complementing complex 58 kda protein) (p58). [source:swissprot;acc:p54727]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 5475.74\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 5800.97\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 1.05939\vspace{3pt}}\\\hline \multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent 1983\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent exocyst complex component sec3 (bm-012). [source:swissprot;acc:q9nv70]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 6036.68\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 6379.44\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 342.76\vspace{3pt}}\\\cline{2-6} &\parbox{\wcB}{\vspace{3pt}\noindent myosin vi. [source:swissprot;acc:q9um54]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 5475.74\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 5800.97\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 1.05939\vspace{3pt}}\\\hline \multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent 1984\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent kinesin light chain 1 (klc 1). [source:swissprot;acc:q07866]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 6036.73\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 6379.48\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 342.75\vspace{3pt}}\\\cline{2-6} &\parbox{\wcB}{\vspace{3pt}\noindent peroxisomal acyl-coenzyme a thioester hydrolase 2a (ec 3.1.2.2) (peroxisomal long-chain acyl-coa thioesterase 2) (zap128). [source:swissprot;acc:p49753]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 5830.03\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 6176.1\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 1.05936\vspace{3pt}}\\\hline \multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent 1985\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent potassium voltage-gated channel subfamily a member 2 (potassium channel kv1.2) (rbk2) (hbk5) (ngk1) (mk2) (hukiv). [source:swissprot;acc:p16389]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 6674.58\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 7015.93\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 341.35\vspace{3pt}}\\\cline{2-6} &\parbox{\wcB}{\vspace{3pt}\noindent scribble. [source:refseq;acc:nm\_015356]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent Divided\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent 5516.89\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 5844.37\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 1.05936\vspace{3pt}}\\\cline{1-2}\cline{4-6} \multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent 1986\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent lap (leucine-rich repeats and pdz) and no pdz protein. [source:refseq;acc:nm\_018214]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent 5517.24\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 5844.68\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 1.05935\vspace{3pt}}\\\cline{2-6} &\parbox{\wcB}{\vspace{3pt}\noindent peptidylprolyl isomerase-like 4; cyclophilin-type peptidyl-prolyl cis-trans isomerase; ppiase; serologically defined breast cancer antigen ny-br-18. [source:refseq;acc:nm\_139126]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent Subtracted\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent 6083.39\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 6423.12\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 339.73\vspace{3pt}}\\\cline{1-2}\cline{4-6} \multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent 1987\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent hydroxyindole o-methyltransferase (ec 2.1.1.4) (hiomt) (acetylserotonin o-methyltransferase) (asmt). [source:swissprot;acc:p46597]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent 5444.6\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 5783.95\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 339.35\vspace{3pt}}\\\cline{2-6} &\parbox{\wcB}{\vspace{3pt}\noindent peroxisomal acyl-coa thioesterase 2b; likely ortholog of mouse peroxisomal acyl-coa thioesterase 2b. [source:refseq;acc:nm\_152331]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent Divided\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent 5829.74\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 6175.69\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 1.05934\vspace{3pt}}\\\cline{1-2}\cline{4-6} \multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent 1988\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent protein translation factor sui1 homolog gc20. [source:swissprot;acc:o60739]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent 3559.49\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 3360.39\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 1.05925\vspace{3pt}}\\\cline{2-6} &\parbox{\wcB}{\vspace{3pt}\noindent seven in absentia homolog 2. [source:refseq;acc:nm\_005067]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 5399.47\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 5737.79\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 338.32\vspace{3pt}}\\\hline \multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent 1989\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent m-phase inducer phosphatase 2 (ec 3.1.3.48) (dual specificity phosphatase cdc25b). [source:swissprot;acc:p30305]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 4383.34\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 4642.93\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 1.05922\vspace{3pt}}\\\cline{2-6} &\parbox{\wcB}{\vspace{3pt}\noindent mitochondrial ribosomal protein l18. [source:refseq;acc:nm\_014161]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 5396.61\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 5733.93\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 337.32\vspace{3pt}}\\\hline \multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent 1990\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent transcription factor-like protein mrg15 (morf-related gene 15 protein) (mortality factor 4-like 1) (msl3-1 protein) (hspc008/hspc061). [source:swissprot;acc:q9ubu8]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 5045.67\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 5344.06\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 1.05914\vspace{3pt}}\\\cline{2-6} &\parbox{\wcB}{\vspace{3pt}\noindent valyl-trna synthetase 2 (ec 6.1.1.9) (valine--trna ligase 2) (valrs 2) (g7a). [source:swissprot;acc:p26640]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent Subtracted\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent 5096.02\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 5432.63\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 336.61\vspace{3pt}}\\\cline{1-2}\cline{4-6} \multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent 1991\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent seven in absentia homolog 1. [source:refseq;acc:nm\_003031]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent 5394.24\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 5730.73\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 336.49\vspace{3pt}}\\\cline{2-6} &\parbox{\wcB}{\vspace{3pt}\noindent solute carrier family 2, facilitated glucose transporter, member 6 (glucose transporter type 6) (glucose transporter type 9). [source:swissprot;acc:q9ugq3]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent Divided\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent 5429.27\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent 5749.69\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent 1.05902\vspace{3pt}}}\\\cline{1-2} \multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent 1992\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent solute carrier family 2, facilitated glucose transporter, member 8 (glucose transporter type 8) (glucose transporter type x1). [source:swissprot;acc:q9ny64]\vspace{3pt}}&&&&\\\cline{2-6} &\parbox{\wcB}{\vspace{3pt}\noindent ubiquitin. [source:swissprot;acc:p02248]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 7484.98\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 7821.11\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 336.13\vspace{3pt}}\\\hline \multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent 1993\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent nucleoporin like 1. [source:refseq;acc:nm\_014089]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 6174.74\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 6538.73\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 1.05895\vspace{3pt}}\\\cline{2-6} &\parbox{\wcB}{\vspace{3pt}\noindent rac gtpase activating protein 1; gtpase activating protein. [source:refseq;acc:nm\_013277]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent Subtracted\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent 5521.07\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 5856.93\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 335.86\vspace{3pt}}\\\cline{1-2}\cline{4-6} \multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent 1994\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent potassium voltage-gated channel subfamily a member 1 (potassium channel kv1.1) (huki) (hbk1). [source:swissprot;acc:q09470]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent 6682.7\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 7018.29\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 335.59\vspace{3pt}}\\\cline{2-6} &\parbox{\wcB}{\vspace{3pt}\noindent rho guanine nucleotide exchange factor 4 isoform a; apc-stimulated guanine nucleotide exchange factor. [source:refseq;acc:nm\_015320]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 6174.74\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 6538.73\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 1.05895\vspace{3pt}}\\\hline \multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent 1995\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent adaptor-related protein complex 1, mu 1 subunit (mu-adaptin 1) (adaptor protein complex ap-1 mu-1 subunit) (golgi adaptor ha1/ap1 adaptin mu-1 subunit) (clathrin assembly protein assembly protein complex 1 medium chain 1) (clathrin coat assembly protein ap47) (clathrin coat associated protein ap47) (ap-mu chain family member mu1a). [source:swissprot;acc:q9bxs5]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 5684.61\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 6018.72\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 334.11\vspace{3pt}}\\\cline{2-6} &\parbox{\wcB}{\vspace{3pt}\noindent cdc42 guanine exchange factor 9; hpem-2 collybistin. [source:refseq;acc:nm\_015185]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 6174.74\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 6538.73\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 1.05895\vspace{3pt}}\\\hline \multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent 1996\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent polypeptide n-acetylgalactosaminyltransferase 2; udp-galnac transferase 2. [source:refseq;acc:nm\_004481]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 6024.47\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 6356.56\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 332.09\vspace{3pt}}\\\cline{2-6} &\parbox{\wcB}{\vspace{3pt}\noindent survival motor neuron protein (component of gems 1) (gemin1). [source:swissprot;acc:q16637]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent Divided\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent 5047.2\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent 5344.68\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent 1.05894\vspace{3pt}}}\\\cline{1-2} \multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent 1997\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent ras-related c3 botulinum toxin substrate 1 (p21-rac1) (ras-like protein tc25). [source:swissprot;acc:p15154]\vspace{3pt}}&&&&\\\cline{2-6} &\parbox{\wcB}{\vspace{3pt}\noindent similar to expressed sequence ai415388 (fragment). [source:sptrembl;acc:q8n428]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent Subtracted\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent 6024.47\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 6356.56\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 332.09\vspace{3pt}}\\\cline{1-2}\cline{4-6} \multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent 1998\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent adaptor-related protein complex 1, mu 2 subunit (mu-adaptin 2) (adaptor protein complex ap-1 mu-2 subunit) (golgi adaptor ha1/ap1 adaptin mu-2 subunit) (clathrin assembly protein assembly protein complex 1 medium chain 2) (ap-mu chain family member mu1b). [source:swissprot;acc:q9y6q5]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent 5671.62\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 6003.67\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 332.05\vspace{3pt}}\\\cline{2-6} &\parbox{\wcB}{\vspace{3pt}\noindent ras-related c3 botulinum toxin substrate 3 (p21-rac3). [source:swissprot;acc:o14658]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent Divided\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent 5047.2\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent 5344.68\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent 1.05894\vspace{3pt}}}\\\cline{1-2} \multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent 1999\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent nucleoporin 54kda; nucleoporin p54. [source:refseq;acc:nm\_017426]\vspace{3pt}}&&&&\\\cline{2-6} &\parbox{\wcB}{\vspace{3pt}\noindent potassium voltage-gated channel subfamily a member 4 (potassium channel kv1.4) (hk1) (hpcn2) (hbk4) (hukii). [source:swissprot;acc:p22459]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 6688.64\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 7020.02\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 331.38\vspace{3pt}}\\\hline \multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent 2000\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent ras-related c3 botulinum toxin substrate 2 (p21-rac2) (small g protein) (gx). [source:swissprot;acc:p15153]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 5047.2\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 5344.68\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 1.05894\vspace{3pt}}\\\cline{2-6} &\parbox{\wcB}{\vspace{3pt}\noindent similar to glucosamine-phosphate n-acetyltransferase (hypothetical protein flj33258). [source:sptrembl;acc:q96ek6]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 5882.61\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 6213.34\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 330.73\vspace{3pt}}\\\hline \multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent 2001\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent dna replication licensing factor mcm5 (cdc46 homolog) (p1-cdc46). [source:swissprot;acc:p33992]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 5047.2\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 5344.68\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 1.05894\vspace{3pt}}\\\cline{2-6} &\parbox{\wcB}{\vspace{3pt}\noindent splicing coactivator subunit srm300; rna binding protein; at-rich element binding factor. [source:refseq;acc:nm\_016333]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent Subtracted\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent 5448.35\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent 5777.35\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent 329\vspace{3pt}}}\\\cline{1-2} \multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent 2002\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent splicing factor u2af 35 kda subunit (u2 auxiliary factor 35 kda subunit) (u2 snrnp auxiliary factor small subunit). [source:swissprot;acc:q01081]\vspace{3pt}}&&&&\\\cline{2-6} &\parbox{\wcB}{\vspace{3pt}\noindent survival of motor neuron protein-interacting protein 1 (smn- interacting protein 1) (component of gems 2) (gemin2). [source:swissprot;acc:o14893]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent Divided\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent 5047.2\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent 5344.68\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent 1.05894\vspace{3pt}}}\\\cline{1-2} \multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent 2003\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent probable atp-dependent rna helicase ddx20 (dead-box protein 20) (dead- box protein dp 103) (component of gems 3) (gemin3). [source:swissprot;acc:q9uhi6]\vspace{3pt}}&&&&\\\cline{2-6} &\parbox{\wcB}{\vspace{3pt}\noindent rna helicase-related protein; rna helicase-like protein; sf3b125 dead-box protein. [source:refseq;acc:nm\_007372]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent Subtracted\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent 5448.35\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent 5777.35\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent 329\vspace{3pt}}}\\\cline{1-2} \parbox{\wcA}{\vspace{3pt}\noindent 2004\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent splicing factor u2af 65 kda subunit (u2 auxiliary factor 65 kda subunit) (u2 snrnp auxiliary factor large subunit) (hu2af(65)). [source:swissprot;acc:p26368]\vspace{3pt}}&&&&\\\hline nd{longtable}
Legend:
- Rank is the rank after comparing the two networks
- Gene is the ensembl human gene identifier measured by 1 or more probes on the microarray
- Value Type describes how the microarray measurement was processed. Ranked indicates that we sorted all measurements and use the rank as red and green value. Measured is the normal measurement. Squared and Rooted are the square and square root respecitcely. This might be valueable to compensate for non linear light distributions.
- Network Comparison Type describes whether we divided the red and green types or whether we sutractcted them
- Interaction Map specifies whether we used only the hig hconfidence protein-protein interactions or also included the low confidence interactions.
- Filtered specifies whether we only included the high confidence microarry measurements or not.

- http://analysis.yellowcouch.org/